Related Experiment Video
Updated: Apr 3, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
III Italian Consensus Conference on Malignant Mesothelioma of the Pleura. Epidemiology, Public Health and
C Magnani1, C Bianchi, E Chellini
1Dipartimento di Medicina Traslazionale - Università del Piemonte Orientale. corrado.magnani@med.unipmn.it.
Abstract:
The III Italian Consensus Conference on Pleural Mesothelioma (MM) convened on January 29th 2015. This report presents the conclusions of the 'Epidemiology, Public Health and Occupational Medicine' section. MM incidence in 2011 in Italy was 3.64 per 100,000 person/years in men and 1.32 in women. Incidence trends are starting to level off. Ten percent of cases are due to non-occupational exposure. Incidence among women is very high in Italy, because of both non-occupational and occupational exposure. The removal of asbestos in place is proceeding slowly, with remaining exposure. Recent literature confirms the causal role of chrysotile. Fibrous fluoro-edenite was classified as carcinogenic by IARC (Group 1) on the basis of MM data. A specific type (MWCNT-7) of Carbon Nanotubes was classified 2B. For pleural MM, after about 45 years since first exposure, the incidence trend slowed down; with more studies needed. Cumulative exposure is a proxy of the relevant exposure, but does not allow to distinguish if duration or intensity may possibly play a prominent role, neither to evaluate the temporal sequence of exposures. Studies showed that duration and intensity are independent determinants of MM. Blood related MM are less than 2.5%. The role of BAP1 germline mutations is limited to the BAP1 cancer syndrome, but negligible for sporadic cases. Correct MM diagnosis is baseline; guidelines agree on the importance of the tumor gross appearance and of the hematoxylin-eosin-based histology. Immunohistochemical markers contribute to diagnostic confirmation: the selection depends on morphology, location, and differential diagnosis. The WG suggested that 1) General Cancer Registries and ReNaM Regional Operational Centres (COR) interact and systematically compare MM cases; 2) ReNaM should report results presenting the diagnostic certainty codes and the diagnostic basis, separately; 3) General Cancer Registries and COR should interact with pathologists to assure the up-to-date methodology; 4) Necroscopy should be practiced for validation. Expert referral centres could contribute to the definition of uncertain cases. Health surveillance should aim to all asbestos effects. No diagnostic test is recommended for MM screening. Health surveillance should provide information on risks, medical perspective, and smoking cessation. The economic burden associated to MM was estimated in 250,000 Euro per case.
Insights
Pleural mesothelioma (MM) incidence is leveling off in Italy, with non-occupational exposure contributing to cases, especially in women. Asbestos removal is slow, and chrysotile remains a confirmed cause of MM.
Area of Science:
- Epidemiology and Public Health
- Occupational Medicine
- Environmental Carcinogenesis
Background:
- Pleural mesothelioma (MM) incidence trends in Italy show a leveling off, with specific figures for men (3.64/100,000) and women (1.32/100,000) in 2011.
- Non-occupational exposure accounts for 10% of MM cases, with a notably high incidence in women attributed to both occupational and non-occupational factors.
- Continued slow removal of asbestos in place indicates ongoing exposure risks.
Framework:
- Recent literature confirms chrysotile asbestos as a causal agent for MM.
- Fibrous fluoro-edenite is classified as a Group 1 carcinogen (IARC), and MWCNT-7 Carbon Nanotubes as Group 2B, based on MM data.
- The latency period for pleural MM is approximately 45 years post-exposure, with incidence trends slowing thereafter, necessitating further research.
Implementation:
- Both exposure duration and intensity are identified as independent determinants of MM risk.
- Genetic factors, such as BAP1 germline mutations, are relevant for BAP1 cancer syndrome but not significant for sporadic MM cases.
- Accurate diagnosis relies on gross tumor appearance, hematoxylin-eosin histology, and specific immunohistochemical markers, guided by morphology and differential diagnosis.
Implications:
- Recommendations include enhanced collaboration between Cancer Registries and the National Mesothelioma Registry (ReNaM) for systematic case comparison and reporting.
- Pathologist engagement is crucial for updating diagnostic methodologies, with necroscopy suggested for validation.
- Health surveillance should encompass all asbestos-related effects, emphasizing risk communication, medical guidance, and smoking cessation; no MM screening tests are recommended.
Related Concept Videos
Pleural Disorders: Types and Brief Description
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleura of the Lungs
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Pneumothorax-II
Clinical Manifestations:
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.

